首页> 外文会议>Annual NSTI nanotechnology conference and expo >Study Of The Correlations Between Direct Electron Transfer Rate Constants And The Effectiveness Of Cancer Inhibitors Using Nanobiomimetic Sensors
【24h】

Study Of The Correlations Between Direct Electron Transfer Rate Constants And The Effectiveness Of Cancer Inhibitors Using Nanobiomimetic Sensors

机译:使用纳米仿生传感器研究直接电子传输速率常数与癌症抑制剂功效之间的相关性

获取原文

摘要

We report a new systematic approach to study Direct Electron Transfer (DET) rate constants between an electrode surface and an active biomimetic receptor site using four types of gold nanobiomimetic sensor chips. The DET results were obtained under antibody-free, label-free and analyte-free conditions in cell culture media using a cyclic voltammetry (CV) method. Sensor 1 has 20 nm nanopores, Sensor 2 has 40 nm nanopores, Sensor 3 has nano islands and Sensor 4 has a flat nano bridge with nanopores. The DET k_s results are sensor 4>sensor 3>sensorl>sensor 2. Anti-cancer compounds l-Methyl-2-piperidinemethanol (MPPDM), Flavopiridol hydrochloride hydrate (FLAPHH) and o-nitrophenyl acetate (o-NPA) were used for evaluation of brain cancer cells of SNB-19 by a Chronoamperometric (CA) method and a CV method. Results shown the MPPDM and o-NPA completely blocked cancer signaling with sensor 4 at 5 cancer cells/mL, while sensor 3 was unable to detect at this level. Cancer detection rate is 97 ± 6% and 90 ± 4% for a CV and a double step chronopotentiometry (DSCPO) method, respectively at 50 cell/mL using cancer spiked NIST human standard sera SRM 965A against that of the samples in the media. Our preliminary results revealed the higher DET values may have a positive correlation to the effectiveness of the anti cancer compounds.
机译:我们报告了一种新的系统方法来研究使用四种类型的金纳米仿生传感器芯片在电极表面和活性仿生受体位点之间的直接电子转移(DET)速率常数。使用循环伏安法(CV)在无抗体,无标记和无分析物的条件下,在细胞培养基中获得DET结果。传感器1具有20 nm纳米孔,传感器2具有40 nm纳米孔,传感器3具有纳米岛,传感器4具有带有纳米孔的扁平纳米桥。 DET k_s结果为传感器4>传感器3>传感器>传感器2。使用了抗癌化合物1-甲基-2-哌啶甲醇(MPPDM),盐酸氟哌啶醇水合物(FLAPHH)和乙酸邻硝基苯酯(o-NPA)计时安培(CA)方法和CV方法评估SNB-19的脑癌细胞。结果显示,MPPDM和o-NPA在5个癌细胞/ mL的情况下完全用传感器4阻断了癌症信号传导,而传感器3无法在此水平上检测到。对于CV和双步计时电位法(DSCPO)方法,使用加标有NIST人标血清SRM 965A的NIST人标准血清相对于培养基中的样品,在50细胞/ mL下的癌症检出率分别为97±6%和90±4%。我们的初步结果表明,较高的DET值可能与抗癌化合物的有效性呈正相关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号